EVALUATION THE LEFT VENTRICULAR FUNCTION BEFORE AND AFTER IMPLANTATION OF CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICE BY USING TISSUE DOPPLER ECHOCARDIOGRAPHY
Main Article Content
Abstract
Objectives: We aimed to evaluate the left ventricular function before and after implantation of cardiac resynchronization therapy (CRT) device by using tissue Doppler echocardiography. Methods: A prospective longitudinal follow-up in 33 patients with severe heart failure (left ventricular ejection fraction ≤ 35%) and QRS duration ≥ 120 ms, who underwent a CRT device implantation in Vietnam National Heart Institute - Bach Mai Hospital. Results: The mean age was 60 years old and the proportion of males was 84,8 %. The pre-implantation baseline QRS duration was 133.9 ms. At the time of discharge, 1 month and 3 months follow-up after implantation, the QRS duration was 124.4 ms; 115.6 ms; 111.8 ms, respectively. The severity of mitral regurgitation was improved and the systolic pulmonary artery pressure was decreased significantly after CRT implantation and during follow-up (p<0.05). The diastolic left ventricular function improved significantly from 1 month follow-up after CRT implantation with a decrease in the E/e' index, and e', a' and s' indices were increased (p<0.05). The left ventricular global longitudinal strain was improved significantly from 1 month follow-up after CRT implantation. Conclusions: Patients, who underwent CRT implantation, had a reduction of the QRS duration from 133.9 ms to 111.8 ms after 3 months follow-up. The severity of mitral regurgitation was decreased, and the pulmonary artery systolic pressure was decreased after CRT implantation. The diastolic left ventricular function and the left ventricular global longitudinal strain were improved significantly from 1 month follow-up after CRT implantation.
Article Details
Keywords
Echocardiography, heart failure, myocardial resynchronization
References
2. WHO 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases.
3. Yancy, Clyde W., et al. "2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines." Circulation 128.16 (2013): 1810-1852.
4. Heidenreich, Paul A., et al. "Does age influence cardiac resynchronization therapy use and outcome?." JACC: Heart Failure 3.6 (2015): 497-504.
5. Molhoek, Sander G., et al. "QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end‐stage heart failure." Pacing and clinical electrophysiology 27.3 (2004): 308-313.
6. Molhoek, Sander G., et al. "QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end‐stage heart failure." Pacing and clinical electrophysiology 27.3 (2004): 308-313.
7. Lapidot, Daniel, et al. "QRS Narrowing Following CRT Implantation: Predictors, Dynamics, and Association with Improved Long-Term Outcome." Journal of Clinical Medicine 11.5 (2022): 1279.
8. Solis, Jorge, et al. "Mechanism of decrease in mitral regurgitation after cardiac resynchronization therapy: optimization of the force–balance relationship." Circulation: Cardiovascular Imaging 2.6 (2009): 444-450.
9. Galli, E., et al. "Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy." International Journal of Cardiology 331 (2021): 144-151.
10. van Everdingen, Wouter M., et al. "Comparison of strain imaging techniques in CRT candidates: CMR tagging, CMR feature tracking and speckle tracking echocardiography." The international journal of cardiovascular imaging 34.3 (2018): 443-456.